Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin and Subcutaneous Tissue Bacterial Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Not applicableActive Not RecruitingNCT06796231
What this trial is testing

Efficacy of PD-1 Monoclonal Antibody in the Treatment of Phaeohyphomycosis

Who this might be right for
Phaeohyphomycosis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Very early researchWithdrawnNCT04084665
What this trial is testing

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Who this might be right for
Hidradenitis Suppurativa
Rockefeller University
Post-approval studies (Phase 4)Not Yet RecruitingNCT07261072
What this trial is testing

Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS

Who this might be right for
Hidradenitis Suppurativa (HS)Hidradenitis Suppurativa (Acne Inversa)Secukinumab
Peking Union Medical College 30
Testing effectiveness (Phase 2)Looking for participantsNCT07630714
What this trial is testing

Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 24
Very early researchLooking for participantsNCT06326476
What this trial is testing

Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.

Who this might be right for
Hidradenitis Suppurativa
University of Alabama at Birmingham 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06768671
What this trial is testing

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

Who this might be right for
Hidradenitis Suppurativa
MoonLake Immunotherapeutics AG 35
Large-scale testing (Phase 3)Study completedNCT01170221
What this trial is testing

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 667